EBV-Positive primary central nervous system lymphomas in monozygote twins with common variable immunodeficiency and suspected multiple sclerosis

Leukemia and Lymphoma

Volumn 28, Issue 1-2, 1997, Pages 187-193

  Krogh Jensen, Morten ^a   Koch Henriksen, Niels ^a   Johansen, Preben ^a   Varming, Kim ^a   Christiansen, Claus Bohn ^b   Knudsen, Flemming ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Common variable immunodeficiency; Epstein Barr virus; Multiple sclerosis; Non Hodgkin's lymphoma; Primary central nervous system lymphoma

Indexed keywords

IMMUNOGLOBULIN; PROTEIN BCL 2; PROTEIN P53; VIRUS RNA;

ADULT; ARTICLE; BRAIN LYMPHOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IN SITU HYBRIDIZATION; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

EID: 6844242316     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709058346     Document Type: Article

References (23)

1. Sneller, M. C., Strober, W., Eisenstein, E., Jaffe, J. S. and Cunningham-Rundles, C. (1993). New insights into common variable immunodeficiency. Ann. Intern. Med., 118, 720-730.
2. Buckley, R. H. (1992). Immunodeficiency diseases. JAMA, 268, 2797-2806.
3. Cunningham-Rundles, C., Kazbay, K., Hasset, J., Zhou, Z. and Mayer, L. (1994). Enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2. N. Eng. J. Med., 331, 918-921.
4. Hermaszewski, R. A. and Webster, A. D. B. (1993). Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med., 86, 31-42.
5. Cunningham-Rundles, C., Lieberman, P., Hellman, G. and Chaganti, R. S. K. (1991). Non-Hodgkin lymphoma in common variable immunodeficiency. Am. J. Hematol., 37, 69-74.
6. Filipovich, A. H., Mathur, A., Kamat, D. and Shapiro, R. S. (1992). Primary immunodeficiencies: genetic risk factors for lymphoma. Canc. Res. (Suppl), 52, 5464-5467.
7. Knowles, D. M., Chamulak, G. A., Subar, M., Burke, J. S., Dugan, M., Wernz, J., Slywotzky, C., Pelicci, P.-G., Dalla-Favera, R. and Raphael, B. (1988). Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann. Inter. Med., 108, 744-753.
8. Sander, C. A., Medeiros, L. J., Weiss, L. M., Yano, T., Sneller, M. C. and Jaffe, E. S. (1992). Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am. J. Surg. Pathol., 16, 1170-1182.
9. Fazekas, F., Offenbacher, H., Fuchs, S., Schmidt, R., Niederkorn, K., Homer, S. and Lechner, H. (1988). Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology, 38, 1822-1825.
10. d'Amore, F., Johansen, P., Houmand, A., Weisenburger, D. D. and Mortensen, L. S. (1996). Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in non-lymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood, 87, 1045-1055.
11. Lennert, K. and Feller, A. C. (1992). Histopathology of non-Hodgkin's lymphoma (Springer Verlag: Berlin.)
12. Krogh-Jensen, M., d'Amore, F., Jensen, M. K., Christensen, B. E., Thorling, K., Pedersen, M., Johansen, P., Boesen, A. M. and Andersen, E. (1995). Clinicopathologic features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumours in a well-defined geographical area. Leuk. Lymphoma, 19, 223-233.
13. Joncas, J. H., Russo, P., Brochu, P., Simard, P., Brisebois, J., Dubé, J., Marton, D., Leclerc, J. M., Hume, H. and Rivard, G. E. (1990). Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J. Clin. Oncol., 8, 378-384.
14. List, A. F., Greco, F. A. and Vogler, L. B. (1987). Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J. Clin. Oncol., 5, 1673-1689.
15. Hamilton-Dutoit, S. J., Raphael, M., Audouin, J., Diebold, J., Lisse, I., Pedersen, C., Oksenhendler, E., Marelle, L. and Pallesen, G. (1993). In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood, 82, 619-624.
16. Geddes, J. F., Bhattacharjee, M. B., Savage, K., Scaravilli, F. and McLaughlin, J. E. (1992). Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome. J. Clin. Pathol., 45, 587-590.
17. Karp, J. E. and Broder, S. (1992). The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention. Leuk. Lymphoma, 8, 167-188.
18. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G. and Wiman, K. G. (1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90, 5455-5459.
19. Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E. and Rickinson, A. B. (1994). Upregulation of bcl-2 by Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response this is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol., 68, 5602-5612.
20. Ferracini, R., Pileri, S., Bergmann, M., Sabattini, E., Rigobello, L., Gambacorta, M., Galli, C., Manetto, V., Frank, G., Godano, U., Spagnolli, F., Casadei, G., Azzolini, U., Falini, B. and Gulotta, F. (1993). Non-Hodgkin lymphomas of the central nervous system. Clinico-pathologic and immunohistochemical study of 147 cases. Path. Res. Pract., 189, 249-260.
21. Kinlen, L. J., Webster, A. D. B., Bird, A. G., Haile, R., Peto, J., Soothill, J. F. and Thompson, R. A. (1985). Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet, 1, 263-266.
22. Filipovich, A. H. and Shapiro, R. S. (1991). Tumors in patients with common variable immunodeficiency. EOS-J. Immunol. Immunopharmacol, 11, 43-46.
23. DeAngelis, L. M. (1995). Current management of primary central nervous system lymphoma. Oncology, 9, 63-71.